Official UK procurement notice
Proprietary Drugs · UK public procurement notice
Authority: eTenderwales·Consortium: 2 public authorities
What is being bought
Published requirement descriptionProprietary Drugs
CPV: Pharmaceutical products
The lotProcurement structure
single lot · no lot value publishedLot #1SuppliesAwardedRenewal
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (4)
- Financial (overall cost of contract): 85
- Price: 65
- Price stability: 20
- Social Value/Community Benefits: 15
Published award criteria (5)
- Product Quality/Acceptability: Pass/Fail
- Financial (overall cost of contract): 85
- Social Value/Community Benefits: 15
- Price: 65
- Price stability: 20
- Suitability
Any supplier may be disqualified who does not respond to the following in the
requisite manner:
- ENTERING GENERAL Qualification SUPPLIER INFORMATION NHS Wales Shared Services Partnership Procurement Services utilizes Sell2Wales to manage and assess general prequalification information in the form of a profile.
Candidates are requested to Register company information on the Sell2Wales website at ww.sell2wales.co.uk.
- SUBMISSION OF TENDER AND PROCUREMENT SPECIFIC INFORMATION
(i)Candidates should register on the NHS Wales Shared Services Partnership Procurement Services eTendering portal etenderwales.bravosolution.co.uk/nhs ↗
(ii) Once registered, candidates must submit their tender as follows a) login to NHS Wales Shared Services Partnership Procurement Services eTendering portal b) select 'Respond to OJEU advert and ITT c) select 'ITTs Open To All Suppliers' d) access listing relating to the contract (title Lenalidomide) and view details e) click on 'Express Interest' button in the 'Actions' box on the left hand side of the page
(iii) Once you have expressed interest, the ITT will move to 'My ITTs', where you can download additional documentation and where you can construct your reply as instructed. You must then publish your reply using the publish button
(iv) For any support in submitting your tender, please contact the eTendering helpdesk on 08000112470 or at [email protected]
- Price carries 170 of 185 points: a 10% discount moves about 17 points. This one is won on the number: sharpen the price before polishing the prose.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Yes
- First published
- 15 Oct 2024, 15:45 BST
- Last source update
- 28 Jul 2025, 11:04 BST
- Award evaluation window
- 15 Nov 2024 – …
- Authority reference
PAD-OJEU-56769- FTS notice number
2025/S 000-043355- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-04ac47Find a Tender
Publisher note: 1. The contracting authority reserves the right to use an electronic reverse auction. 2. If and when this requirement is offered for tender, this may be done in whole or in part via electronic means using the internet. 3. The contracting authority is not bound to award a contract in whole or part. 4. The contracting authority will not bear the tender costs of any of the tenderers. 5. In reference to I.1.9 (Variants) to the extent permitted, if at all, in the tender documents. 6. This notice is being placed by NHS Wales Shared Services Partnership – Procurement Services. For the purpose of this procurement, the awarding authority will be Velindre NHS Trust. 7. This advertisement is placed by NHS Wales Shared Services Partnership - Procurement Services on behalf of participating LHB's/Trusts in Wales for the totality of those LHB/Trust specific contractual arrangements. 8. The Framework to be let for 3 years with an option to extend for 12months
How it was run
Official noticeTender documents are also served through a separate tool: http://www.etenderwales.bravosolution.co.uk/nhs/ ↗
- Submission deadline
- 15 Nov 2024, 12:00 GMT
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Participation fee
- document
- Bids opened
- 15 Nov 2024, 12:01 GMT
Timeline
15 Nov 2024 → 28 Jul 2025 · 4 dates- Submission deadline15 Nov 2024, 12:00 GMT
- Bids opened15 Nov 2024, 12:01 GMT
- Contract starts1 Jul 2025, 00:00 BST
- Notice published28 Jul 2025, 11:04 BST
Notice history
2 events · 2 releases on Find a Tender · since 28 Jul 2025- Status changed to complete28 Jul 2025, 11:04 BST
- Buyer details updated28 Jul 2025, 11:04 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Abbvie Ltd | £3,883,000 † | — | Awarded |
| Astra Zenica | £11,689,400 † | — | Awarded |
| Baxter Healthcare LtdSME | £430,200 † | — | Awarded |
| Bayer Plc | £46,964,600 † | — | Awarded |
| Biogen Idec Ltd | £948,600 † | — | Awarded |
| Camurus AB | £10,585,600 † | — | Awarded |
| Chiesi Limited | £6,368,400 † | — | Awarded |
| Chugai Pharma UK Ltd | £310,800 † | — | Awarded |
| Cipla EU Limited | £138,200 † | — | Awarded |
| Colonis Pharma Ltd | £11,800 † | — | Awarded |
62 further award records carry no date or value.
Contracts
Proprietary Drugs · Abbvie Ltd
- Signed
- 27 Jun 2025
- Value
- £3,883,000
- Period
- … – 30 Jun 2028
- Status
- active
Proprietary Drugs · Astra Zenica
- Signed
- 17 Jun 2025
- Value
- £11,689,400
- Period
- … – 30 Jun 2028
- Status
- active
Proprietary Drugs · Baxter Healthcare LtdSME
- Signed
- 17 Jun 2025
- Value
- £430,200
- Period
- … – 30 Jun 2028
- Status
- active
Proprietary Drugs · Bayer Plc
- Signed
- 17 Jun 2025
- Value
- £46,964,600
- Period
- … – 30 Jun 2028
- Status
- active
Proprietary Drugs · Biogen Idec Ltd
- Signed
- 17 Jun 2025
- Value
- £948,600
- Period
- … – 30 Jun 2028
- Status
- active
Proprietary Drugs · Camurus AB
- Signed
- 17 Jun 2025
- Value
- £10,585,600
- Period
- … – 30 Jun 2028
- Status
- active
Proprietary Drugs · Chiesi Limited
- Signed
- 17 Jun 2025
- Value
- £6,368,400
- Period
- … – 30 Jun 2028
- Status
- active
Proprietary Drugs · Chugai Pharma UK Ltd
- Signed
- 17 Jun 2025
- Value
- £310,800
- Period
- … – 30 Jun 2028
- Status
- active
Proprietary Drugs · Cipla EU Limited
- Signed
- 17 Jun 2025
- Value
- £138,200
- Period
- … – 30 Jun 2028
- Status
- active
Proprietary Drugs · Colonis Pharma Ltd
- Signed
- 17 Jun 2025
- Value
- £11,800
- Period
- … – 30 Jun 2028
- Status
- active
Proprietary Drugs
- Signed
- 17 Jun 2025
- Value
- £1,298,400
- Period
- … – 30 Jun 2028
- Status
- active
Proprietary Drugs
- Signed
- 17 Jun 2025
- Value
- £1,795,400
- Period
- … – 30 Jun 2028
- Status
- active
Proprietary Drugs
- Signed
- 17 Jun 2025
- Value
- £100,000
- Period
- … – 30 Jun 2028
- Status
- active
Proprietary Drugs
- Signed
- 17 Jun 2025
- Value
- £779,000
- Period
- … – 30 Jun 2028
- Status
- active
Proprietary Drugs
- Signed
- 17 Jun 2025
- Value
- £3,423,200
- Period
- … – 30 Jun 2028
- Status
- active
Proprietary Drugs
- Signed
- 17 Jun 2025
- Value
- £22,355,800
- Period
- … – 30 Jun 2028
- Status
- active
Proprietary Drugs
- Signed
- 17 Jun 2025
- Value
- £32,600
- Period
- … – 30 Jun 2028
- Status
- active
Proprietary Drugs
- Signed
- 17 Jun 2025
- Value
- £41,000
- Period
- … – 30 Jun 2028
- Status
- active
Proprietary Drugs
- Signed
- 17 Jun 2025
- Value
- £331,050
- Period
- … – 30 Jun 2028
- Status
- active
Proprietary Drugs
- Signed
- 17 Jun 2025
- Value
- £436,800
- Period
- … – 30 Jun 2028
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 75bids | — | — | — |
Contracting authority & participating public bodies
2 public bodies on the noticeConsortium members and other public bodies
- Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)Contracting authorityCentral purchasing bodyBody governed by public lawHealth
Bidders & participating suppliers
72 commercial parties on the notice · 50 awardedThe first 50 of 72 commercial parties (by name); the JSON mirror lists them all.
- AMO United Kingdom LtdAwarded supplier
- Abbvie LimitedAwarded supplier
- Accord UK LimitedAwarded supplier
- Alliance Pharmaceuticals LimitedAwarded supplier
- AmaroxAwarded supplier
- Amicus Therapeutics UK Operations LtdAwarded supplier
- Aspen Pharmacare UK LimitedAwarded supplier
- Aspire Pharma LtdAwarded supplier
- Astellas Pharma LtdAwarded supplier
- Astra ZenicaAwarded supplier
Show 40 more suppliers
- Baxter Healthcare LimitedAwarded supplier
- Bayer PlcAwarded supplier
- Biogen Idec LimitedAwarded supplier
- CST PharmaAwarded supplier
- Camurus ABAwarded supplier
- Chiesi LimitedAwarded supplier
- Chugai Pharma UK LtdAwarded supplier
- Cipla EU LimitedAwarded supplier
- Colonis Pharma LtdAwarded supplier
- Dr Falk Pharma UK LtdAwarded supplier
- Dr Reddy's Laboratories (UK) LtdAwarded supplier
- Eisai LimitedAwarded supplier
- Eli Lilly & Company LtdAwarded supplier
- Essential PharmaAwarded supplier
- Esteve PharmaceuticalsAwarded supplier
- Ferring Pharmaceuticals LtdAwarded supplier
- Flynn Pharma LtdAwarded supplier
- Focus Pharmaceuticals LtdAwarded supplier
- Galen LimitedAwarded supplier
- Gedeon RichterAwarded supplier
- Glaxo SmithklineAwarded supplier
- Glenmark PharmaceuticalsAwarded supplier
- IBSA Pharma LtdAwarded supplier
- Ipsen LimitedAwarded supplier
- Janssen LimitedAwarded supplier
- Juvise PharmaceuticalsAwarded supplier
- Kent PharmaceuticalsAwarded supplier
- Kyowa Kirin International UK Newco LtdAwarded supplier
- Lupin Healthcare (UK) LimitedAwarded supplier
- Luye Pharma LtdAwarded supplier
- MartindaleAwarded supplier
- Mercury Pharmaceuticals LtdAwarded supplier
- Merz Pharma UK LtdAwarded supplier
- Morningside Pharmaceuticals LimitedAwarded supplier
- Napp Pharmaceutical Group LtdAwarded supplier
- Neon Healthcare LtdAwarded supplier
- Novartis Pharmaceuticals UK LimitedAwarded supplier
- Novo Nordisk Pharmaceuticals LtdAwarded supplier
- Organon Pharma (UK) LimitedAwarded supplier
- Orion Pharma UK LtdAwarded supplier
Official documents & specifications (2)
Official links; attachments are not copiedTender pack and attachments
- Economic and financial selection criteria
- Technical selection criteria